3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Colorectal Neoplasms
26
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
15
Head and Neck Neoplasms
13
Rectal Neoplasms
11
Colonic Neoplasms
11
Prostatic Neoplasms
8
Pancreatic Neoplasms
7
Mouth Neoplasms
6
Glioblastoma
6
Neuroblastoma
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Recurrence
4
Precancerous Conditions
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasms
4
Liver Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Gliosarcoma
4
Carcinoma, Hepatocellular
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Interventions
Cyclophosphamide
16
Temozolomide
13
Vincristine
10
Irinotecan
8
Melphalan
7
Doxorubicin
7
Topotecan
6
Granulocyte Colony-Stimulating Factor
6
Busulfan
6
fludarabine
5
cabozantinib
5
Etoposide
5
Drug Therapy
5
liposomal doxorubicin
4
Sirolimus
4
Ifosfamide
4
Filgrastim
4
regorafenib
3
pegfilgrastim
3
irinotecan sucrosofate
3
fludarabine phosphate
3
Zoledronic Acid
3
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Cisplatin
3
Bone Marrow Transplantation
3
Albumin-Bound Paclitaxel
3
pegylated granulocyte colony-stimulating factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Ewing
×
Celecoxib
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled